Loss of BRCA1 leads to an increased sensitivity to Bisphenol A

Toxicology Letters

Volumn 199, Issue 3, 2010, Pages 261-268

  Jones, Laundette P ^a   Sampson, Aishia ^a   Kang, Hyo Jin ^b   Kim, Hee Jeong ^b   Yi, Yong Weon ^b   Kwon, Sun Young ^d   Babus, Janice K ^a   Wang, Antai ^e   Bae, Insoo ^b,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c Dankook University   (South Korea)

^d Keimyung University   (South Korea)

^e Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Bisphenol A; Brca1; Mammary gland; Mice

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; BRCA1 PROTEIN; ESTROGEN RECEPTOR ALPHA; SMALL INTERFERING RNA; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CELL CULTURE; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LOSS OF FUNCTION MUTATION; MAMMARY GLAND; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; BRCA1 PROTEIN; CELL LINE, TUMOR; CELL PROLIFERATION; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; MAMMARY GLANDS, ANIMAL; MICE; MICE, INBRED C57BL; PHENOLS; TAMOXIFEN;

MUS;

EID: 78650509636     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2010.09.008     Document Type: Article

References (29)

1. Calafat A.M., Kuklenyik Z., Reidy J.A., Caudill S.P., Ekong J., Needham L.L. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ. Health Perspect. 2005, 113:391-395.
2. Calafat A.M., Ye X., Wong L.Y., Reidy J.A., Needham L.L. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ. Health Perspect. 2008, 116:39-44.
3. Fan S., Wang J., Yuan R., Ma Y., Meng Q., Erdos M.R., Pestell R.G., Yuan F., Auborn K.J., Goldberg I.D., Rosen E.M. BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science 1999, 284:1354-1356.
4. Fan S., Ma Y.X., Wang C., Yuan R.Q., Meng Q., Wang J.A., Erdos M., Goldberg I.D., Webb P., Kushner P.J., Pestell R.G., Rosen E.M. Role of direct interaction in BRCA1 inhibition of estrogen receptor activity. Oncogene 2001, 20:77-87.
5. Friedman L.S., Ostermeyer E.A., Lynch E.D., Szabo C.I., Anderson L.A., Dowd P., Lee M.K., Rowell S.E., Boyd J., King M.C. The search for BRCA1. Cancer Res. 1994, 54:6374-6382.
6. Harkin D.P., Bean J.M., Miklos D., Song Y.H., Truong V.B., Englert C., Christians F.C., Ellisen L.W., Maheswaran S., Oliner J.D., Harber D.A. Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell 1999, 97:575-586.
7. Hess-Wilson J.K., Boldison J., Weaver K.E., Knudsen K.E. Xenoestrogen action in breast cancer: impact on ER-dependent transcription and mitogenesis. Breast Cancer Res. Treat. 2006, 96:279-292.
8. Jones L.P., Tilli M.T., Assefnia S., Torre K., Halama E.D., Parrish A., Rosen E.M., Furth P.A. Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERα-negative and ERα-positive mammary preneoplasia and cancer. Oncogene 2008, 27:794-802.
9. Keri R.A., Ho S.M., Hunt P.A., Knudsen K.E., Soto A.M., Prins G.S. An evaluation of evidence for the carcinogenic activity of bisphenol A. Reprod. Toxicol. 2007, 24:240-252.
10. Krishnan A.V., Stathis P., Permuth S.F., Tokes L., Feldman D. Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 1993, 132:2279-2286.
11. Markey C.M., Rubin B.S., Soto A.M., Sonnenschein C. Endocrine disruptors: from wingspread to environmental developmental biology. J. Steroid Biochem. Mol. Biol. 2002, 83:235-244.
12. Narod S.A., Foulkes W.D. BRCA1 and BRCA2: 1994 and beyond. Nat. Rev. Cancer 2004, 4:665-676.
13. Olea N., Pulgar R., Peres P., Olea-Serrano F., Rivas A., Novillo-Fertrell A., Pedraza V., Soto A.M., Sonnenschein C. Estrogenicity of resin-based composites and sealants used in dentistry. Environ. Health Perspect. 1996, 104:298-305.
14. Olsen C.M., Meussen-Elholm E.T., Samuelsen M., Holme J.A., Hongslo J.K. Effects of the environmental oestrogens bisphenol A, tetrachlorobisphenol A, tetrabromobisphenol A, 4-hydroxybiphenyl and 4,4′-dihydroxybiphenyl on oestrogen receptor binding, cell proliferation and regulation of oestrogen sensitive proteins in the human breast cancer cell line MCF-7. Pharmacol. Toxicol. 2003, 92:180-188.
15. Rosen E.M., Fan S., Isaacs C. BRCA1 in hormonal carcinogenesis: basic and clinical research. Endocr. Relat. Cancer 2005, 12:533-548.
16. Schafer T.E., Lapp C.A., Hanes C.M., Lewis J.B., Wataha J.C., Schuster G.S. Estrogenicity of bisphenol A and bisphenol A dimethacrylate in vitro. J. Biomed. Mater. Res. 1999, 45:192-197.
17. WAF1/CiP1. Nature 1997, 389:187-190.
18. Soto A.M., Sonnenschein C., Chung K.L., Fernandez M.F., Olea N., Serrano F.O. The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ. Health Perspect. 1995, 103:113-122.
19. Soto A.M., Maffini M.V., Sonnenschein C. Neoplasia as development gone awry: the role of endocrine disruptors. Int. J. Androl. 2008, 31:288-293.
20. Tsutsumi O. Assessment of human contamination of estrogenic endocrine-disrupting chemicals and their risk for human reproduction. J. Steroid Biochem. Mol. Biol. 2005, 93:325-330.
21. Vandenberg L.N., Maffini M.V., Sonnenschein C., Rubin B.S., Soto A.M. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr. Rev. 2009, 30:75-95.
22. vom Saal F.S., Akingbemi B.T., Belcher S.M., Birnbaum L.S., Crain D.A., Eriksen M., Farabollini F., Guillette L.J., Hauser R., Heindel J.J., Ho S.M., Hunt P.A., Iguchi T., Jobling S., Kanno J., Keri R.A., Knudsen K.E., Laufer H., LeBlanc G.A., Marcus M., McLachlan J.A., Myers J.P., Nadal A., Newbold R.R., Olea N., Prins G.S., Richter C.A., Rubin B.S., Sonnenschein C., Soto A.M., Talsness C.E., Vandenbergh J.G., Vandenberg L.N., Walser-Kuntz D.R., Watson C.S., Welshons W.V., Wetherill Y., Zoeller R.T. Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod. Toxicol. 2007, 24:131-138.
23. Villalobos M., Olea N., Brotons J.A., Olea-Serrano M.F., Ruiz de Almodovar J.M., Pedraza V. The E-screen assay: a comparison of different MCF7 cell stocks. Environ. Health Perspect. 1995, 103:844-850.
24. Wagner K.U., Wall R.J., St-Onge L., Gruss P., Wynshaw-Boris A., Garrett L., Li M., Furth P.A., Hennighausen L. Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res. 1997, 25:4323-4330.
25. Welshons W.V., Nagel S.C., vom Saal F.S. Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 2006, 147:S56-S69.
26. Wetherill Y.B., Petre C.E., Monk K.R., Puga A., Knudsen K.E. The xenoestrogen bisphenol A induces inappropriate androgen receptor activation and mitogenesis in prostatic adenocarcinoma cells. Mol. Cancer Ther. 2002, 1:515-524.
27. Xu X., Wagner K.U., Larson D., Weaver Z., Li C., Ried T., Hennighausen L., Wynshaw-Boris A., Deng C.X. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat. Genet. 1999, 22:37-43.
28. Yamada H., Furuta I., Kato E.H., Kataoka S., Usuki Y., Kobashi G., Sata F., Kishi R., Fujimoto S. Maternal serum and amniotic fluid bisphenol A concentrations in the early second trimester. Reprod. Toxicol. 2002, 16:735-739.
29. Zheng L., Annab L.A., Afshari C.A., Lee W.H., Boyer T.G. BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:9587-9592.